Mixed connective tissue disease diagnostic study of choice
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease diagnostic study of choice |
FDA on Mixed connective tissue disease diagnostic study of choice |
on Mixed connective tissue disease diagnostic study of choice |
Mixed connective tissue disease diagnostic study of choice in the news |
Blogs onMixed connective tissue disease diagnostic study of choice |
Directions to Hospitals Treating Mixed connective tissue disease |
Risk calculators and risk factors for Mixed connective tissue disease diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Diagnostic Criteria
- The diagnosis of MCTD is made when both of the following diagnostic criteria are met:[1]
- Overlapping clinical features between two or more systemic autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, dermatomyositis, polymyositis, and scleroderma)
- Presence of antibodies against the U1 small nuclear ribonucleoprotein autoantigen (U1snRNP)
References
- ↑ Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S (2014). "The diagnosis and classification of mixed connective tissue disease". J. Autoimmun. 48-49: 46–9. doi:10.1016/j.jaut.2014.01.008. PMID 24461387.